ConductScience.org, home

Trial · NCT00003782

Adverse events192

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherArthralgiaMusculoskeletal and connective tissue disordersDoxorubicin + Cyclophosphamide, Then Docetaxel1261,748
otherArthralgiaMusculoskeletal and connective tissue disordersDoxorubicin + Docetaxel221,748
otherArthralgiaMusculoskeletal and connective tissue disordersDoxorubicin + Docetaxel + Cyclophosphamide331,745
otherDiarrheaGastrointestinal disordersDoxorubicin + Cyclophosphamide, Then Docetaxel781,748
otherDiarrheaGastrointestinal disordersDoxorubicin + Docetaxel661,748
otherDiarrheaGastrointestinal disordersDoxorubicin + Docetaxel + Cyclophosphamide1111,745
otherFatigueGeneral disordersDoxorubicin + Cyclophosphamide, Then Docetaxel2121,748
otherFatigueGeneral disordersDoxorubicin + Docetaxel1351,748
otherFatigueGeneral disordersDoxorubicin + Docetaxel + Cyclophosphamide1671,745
otherFebrile neutropeniaBlood and lymphatic system disordersDoxorubicin + Cyclophosphamide, Then Docetaxel3831,748
otherFebrile neutropeniaBlood and lymphatic system disordersDoxorubicin + Docetaxel2231,748
otherFebrile neutropeniaBlood and lymphatic system disordersDoxorubicin + Docetaxel + Cyclophosphamide2751,745
otherInfections and infestations - Other, specifyInfections and infestationsDoxorubicin + Cyclophosphamide, Then Docetaxel2001,748
otherInfections and infestations - Other, specifyInfections and infestationsDoxorubicin + Docetaxel1441,748
otherInfections and infestations - Other, specifyInfections and infestationsDoxorubicin + Docetaxel + Cyclophosphamide1371,745
otherMyalgiaMusculoskeletal and connective tissue disordersDoxorubicin + Cyclophosphamide, Then Docetaxel1481,748
otherMyalgiaMusculoskeletal and connective tissue disordersDoxorubicin + Docetaxel291,748
otherMyalgiaMusculoskeletal and connective tissue disordersDoxorubicin + Docetaxel + Cyclophosphamide351,745
otherNauseaGastrointestinal disordersDoxorubicin + Cyclophosphamide, Then Docetaxel1621,748
otherNauseaGastrointestinal disordersDoxorubicin + Docetaxel1271,748

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00003782/events